Eisai Banzel is FDA-approved to treat seizures related to Lennox-Gastaut syndrome (LGS). It is approved for this use in combination with other seizure medications. It can be prescribed for adults and children ages 1 year and older.
Campaign was developed that showed a graphic representation of Banzel Patients that had greater control of their daily lifes with the support of their caregivers and the conditions associated with LGS.
The brand was developed for the American market and included Logo development, brand guidelines, all digital platforms, print material, packaging, tactical presentations and video.
Eiasi: Banzel
Eiasi — Banzel Campaign
Eiasi — Banzel Branding Guidelines
Eiasi — Banzel Website and Mobile
Eiasi — Banzel IRep
Eiasi — Banzel Print Sales Aid
Eiasi — Banzel Newsletters
Eiasi — Banzel Tactical Planning Part 1
Eiasi — Banzel Tactical Planning Part 2
Eiasi — Banzel Tactical Planning Part 3
Eiasi — Banzel Tactical Planning Part 4
Eiasi — Banzel Tactical Planning Part 5
Eiasi — Banzel Starter Kit 1
Eiasi — Banzel Starter Kit 2
Eiasi — Banzel Starter Kit 3
Eiasi — Banzel Starter Kit 4